D4476

D4476 is a **small-molecule casein kinase 1 inhibitor** used primarily as a research tool rather than an approved medicine. Across the cited literature, it is consistently described as a selective inhibitor of **casein kinase 1 alpha**, and it is used to probe CK1alpha-dependent signaling in cancer, red blood cell injury, inflammation, infection biology, steroidogenesis, and viral replication. Reported experimental findings link D4476 to modulation of pathways involving ferroptosis, pyroptosis, interferon receptor regulation, alpha-enolase phosphorylation and localization, ovarian granulosa-cell estradiol production, and Rift Valley fever virus replication. The provided evidence supports its identity as an investigational laboratory compound with broad preclinical pharmacology, but not as a clinically developed therapeutic product.

Other names

casein kinase 1 inhibitor D4476CK1 inhibitor D4476CK-1 inhibitor D4476CK 1 inhibitor D4476CK1alpha inhibitor D4476CK-1alpha inhibitor D4476CK 1alpha inhibitor D4476